Prenetics prices $48 million equity offering for IM8 expansion, bitcoin strategy

Prenetics Global Limited (NASDAQ: PRE) announced the pricing of a public offering expected to raise approximately $48 million in gross proceeds. The health sciences company sold 2,992,596 Class A ordinary shares and associated warrants at a combined offering price of $16.08 per share.

The offering includes Class A warrants exercisable at $24.12 per share and Class B warrants exercisable at $32.16 per share. Both warrant classes are immediately exercisable upon issuance for five years following the date of issuance.

The company stated it intends to use proceeds for global expansion of IM8, its consumer supplement brand, and for accumulating Bitcoin as part of what it describes as a health and wealth strategy. Prenetics reported it has been purchasing one Bitcoin per day and holds 275 BTC as of October 27, 2025.

The offering is expected to close on October 28, 2025, subject to customary closing conditions. Dominari Securities LLC served as the sole placement agent for the transaction.

The securities are being offered under a shelf registration statement on Form F-3 that was declared effective by the Securities and Exchange Commission on September 11, 2025.

You May Also Be Interested In

• Outlook Therapeutics names Kevin Lundquist as CFO ahead of U.S. launch
• JATT III Acquisition Corp closes $69M IPO on Nasdaq
• GCL Global launches $10 million share buyback program